UDG Healthcare
1948
FOUNDED
PUBLIC
STATUS
5K-10K
EMPLOYEES
UDG
STOCK SYMBOL
42
INVESTMENTS
$8.79
SHARE PRICE
(As of Wednesday Closing)
Description
UDG Healthcare PLC provides healthcare services in North America, Ireland, the UK, and continental Europe. The firm operates in three segments: Ashfield Commercial and Medical Services, Sharp Packaging Services, and Aquilant Specialist Healthcare Services. The Ashfield Commercial and Medical Services segment generates the majority of revenue. This segment provides services related to sales and marketing, communications, event management, and medical and regulatory affairs. The Sharp Packing Services segment provides commercial and clinical trial packaging services to healthcare companies. The Supply Chain Services segment, which includes Aquilant, is made up of healthcare logistics companies. The largest proportions of revenue are generated in the United Kingdom and North America.
Website
Formerly Known As
United Drug
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
BPO/Outsource Services
Other Industries
Other Healthcare Services
Other Commercial Services
Distributors (Healthcare)
Stock Exchange
LON
Primary Office
- 20 Riverwalk
- Citywest Business Campus
- Dublin 24
- Ireland
+353 (01) 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore UDG Healthcare’s full profile, request a free trial.
UDG Healthcare Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $7.02 - $12.40 | $2.19B | $8.91 | $0.10 | 762K | 249M |
UDG Healthcare Financials Summary
|
In Thousands,
USD |
TTM
31-Mar-2019
|
FY 2018
30-Sep-2018
|
FY 2017
30-Sep-2017
|
FY 2016
30-Sep-2016
|
|---|---|---|---|---|
| Enterprise Value | 1,900,925 | 2,269,613 | 2,710,553 | 2,308,124 |
| Revenue | 1,296,518 | 1,315,186 | 1,219,755 | 1,083,439 |
| EBITDA | 108,956 | 79,505 | 150,677 | 338,837 |
| Net Income | 25,893 | 3,795 | 71,858 | 218,523 |
| Total Assets | 1,540,342 | 1,527,157 | 1,519,949 | 1,400,438 |
| Total Debt | 240,702 | 243,371 | 244,135 | 306,990 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
UDG Healthcare Investments & Acquisitions (42)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000 | 21-May-2019 | 000000000000000000 | 000.00 | Practice Management (Healthcare) | 0000000 000000000 |
| 000000 0000000000 | 21-May-2019 | 000000000000000000 | 000.00 | Consulting Services (B2B) | 0000000 000000000 |
| 000000 00000 000 | 02-Jul-2018 | 000000000000000000 | 000.00 | Media and Information Services (B2B) | 00000 0000000 |
| 000000000000 | 29-Jun-2018 | 000000000000000000 | 0000 | Consulting Services (B2B) | 0000000 000000000 |
| MicroMass Communications | 14-Sep-2017 | Merger/Acquisition | 000.00 | Media and Information Services (B2B) | 0000000 000000000 |
UDG Healthcare Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 0000 | 01-Oct-2014 | 000000000 00000000 | Completed |
|
|
| 00000000000000 000 | 31-Jan-2013 | 000000000000000000 | Completed |
|
|
| 00000 00000000 | 27-Jun-2011 | 000000000000000000 | Completed |
|
|
| 00000 000000 00000 | 01-Aug-2009 | 00000 0000000 | Completed |
|
|
| The Specials Laboratory | 18-Nov-2008 | Merger/Acquisition | 000.00 | Completed |
UDG Healthcare Subsidiaries (13)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Nyxeon | Consulting Services (B2B) | London, United Kingdom | 2013 |
| 00000000 000000 | Practice Management (Healthcare) | London, United Kingdom | 0000 |
| 000000 00000 000 | Media and Information Services (B2B) | New York, NY | 0000 |
| 0000 000000000 | Accounting, Audit and Tax Services (B2B) | London, United Kingdom | 0000 |
| 0000000 | Consulting Services (B2B) | Philadelphia, PA | 0000 |
UDG Healthcare Executive Team (11)
5 Former Executives
You’re viewing 5 of 11 executives. Get the full list »